Hepatitis B Virus
Research results from Chinese University of Hong Kong update knowledge of hepatitis B virus
Published in Hepatitis Weekly, February 11th, 2008
"The efficacy of nucleoside and nucleotide analogues for hepatitis B has been linked to the magnitude and durability of hepatitis B virus (HBV) suppression. To compare the antiviral efficacy of telbivudine and adefovir dipivoxil, and the effects of switching from adefovir to telbivudine, in hepatitis B e antigen (HBeAg)-positive patients with chronic hepatitis B. Randomized, controlled, open-label trial," scientists in Hong Kong, People's Republic of China report.
"16 outpatient clinics. 135 treatment-naive, HBeAg-positive adults with chronic hepatitis B. Patients were randomly assigned in a 1: 1:1 ratio to 52 weeks of telbivudine (group A) or adefovir (group B), or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-02-11)
More Articles from Hepatitis Weekly
- HIV/AIDS
Regular marijuana use increases risk of hepatitis C-related liver damage - Cancer
Investigators at Georgetown University release new data on cancer - Combination Therapy
MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study - Hepatitis
Data on hepatitis described by J. Tanabe et al - Hepatitis B Virus
New findings from K.F. Tang and co-researchers in the area of hepatitis B virus described - Hepatitis B Virus
New hepatitis B virus study results reported from Z. Zhang et al - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
